Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1803963Generated: October 25, 2026

(4S)-4-(Benzoyloxymethyl)oxazolidine-2-one → benzoic acid (R)-3-{4-[4-(4-chlorobenzoyl)piperidine-1-carbonyl]-3-methanesulfonylphenyl}-2-oxooxazolidin-4-ylmethyl ester

https://huagongshe.com/reaction/1803963

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(4S)-4-(Benzoyloxymethyl)oxazolidine-2-oneHCID 16213752—
Reactant(4-Bromo-2-methanesulfonylphenyl)[4-(4-chlorobenzoyl)piperidin-1-yl]methanoneHCID 67380967—
Productbenzoic acid (R)-3-{4-[4-(4-chlorobenzoyl)piperidine-1-carbonyl]-3-methanesulfonylphenyl}-2-oxooxazolidin-4-ylmethyl esterHCID 5475500248.5%

Reaction Steps

By reaction and treatment in the same manner as in Preparation Example 1 and using 4-bromo-2-methylsulfonylbenzoic acid (2.8 g) and (4-chlorophenyl)piperidin-4-ylmethanone (2.6 g), (4-bromo-2-methanesulfonylphenyl)[4-(4-chlorobenzoyl)piperidin-1-yl]methanone (4.8 g) was obtained. By reaction and treatment in the same manner as in Preparation Example 12 and using (4-bromo-2-methanesulfonylphenyl)[4-(4-chlorobenzoyl)piperidin-1-yl]methanone (1.5 g) and benzoic acid (R)-2-oxooxazolidin-4-ylmethyl ester (796 mg), the title compound (938 mg) was obtained.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08354401B2
Source datasetuspto-grants-2013_01
ORD IDord-c9359ff7f8414afd82b5a0102351dfda
Source noteuspto-grants-2013_01